Kyorin Eye Center
Mitaka, Tokyo, 181-8611, Japan
Completed
NCT Number: NCT02120066
Submacular Hemorrhage Associated With Retinal Arterial Macro Aneurysm
Evaluation of surgical outcome of vitrectomy with subretinal injection of recombinant tissue-plasminogen activator for submacular hemorrhage associated with retinal arterial macroanuerysms.
Completed
Looking for future studies?
Notify MeKey information
Age range
40 year–95 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- The patients with sub macular hemorrhage associated with ruptured retinal arterial macro aneurysms
Exclusion criteria
- The eyes with preretinal or intraretinal hemorrhage at the fovea
- The patients with follow-up less than 3 months
Treatment and study plan
Vitrectomy for submacular hemorrhage
Proceduresubretinal injection of tissue-plasminogen activator
DrugPrimary outcomes
-
Displacement of sub macular hemorrhage
Time frame: one year
Anatomical recovery detected funduscopy and optical coherence tomography
Secondary outcomes
-
Visual acuity
Time frame: one year
Visual recovery after surgery
Sponsors and collaborators
Lead sponsor
Kyorin University
Other
Registry information
Important dates
- Study start
- 2011
- Primary completion
- 2013
- Study completion
- 2014
- First posted
- Apr 22, 2014
- Registry last updated
- Apr 22, 2014
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.